Skip to the page

Data / Drug companies / NorthStar RxLLC

NorthStar RxLLC: 383 products in the FDA NDC directory, labeler code 72603

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

NorthStar RxLLC (labeler code 72603) lists 383 products in the FDA National Drug Code Directory, covering 161 finished drugs by generic name. By type: 382 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 30, 2026.

The request: Watch NorthStar RxLLC (FDA labeler code 72603): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72603
Products in commercial distribution
383
Packages
539
Finished drugs by generic name
161
Prescription products
382
Over the counter products
1
Controlled substance products
Schedule II 1, Schedule III 2, Schedule IV 6, Schedule V 9
Flagged as original packager
355 of 355 products that carry the flag
Started marketing in the last 12 months
86
Products with a marketing end date set
8
Earliest marketing start
October 6, 2000
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)38299.7%
Biologics (BLA)10.3%

Products by type

TypeProductsShare
Prescription drugs38299.7%
Over the counter drugs10.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Heparin sodium1123
Levothyroxine sodium1144
Estradiol953
Atorvastatin calcium859
Bupivacaine hydrochloride823
Olanzapine749
Enoxaparin sodium718
Pregabalin754
Atomoxetine719
Lidocaine hydrochloride7134
Dexamethasone645
Midodrine hydrochloride634
Bumetanide642
Dasatinib618
Topiramate556
Doxepin hydrochloride545
Metoprolol succinate446
Everolimus415
Lurasidone hydrochloride428
Clozapine413
Tadalafil454
Nebivolol421
Labetalol hydrochloride443
Ampicillin sodium411
Rosuvastatin calcium434
Diclofenac sodium4109
Doxepin48
Oxaliplatin416
Nitrofurantoin macrocrystals320
Varenicline tartrate323
Irbesartan327
Sildenafil citrate324
Clorazepate dipotassium38
Furosemide363
Tobramycin341
Clonazepam336
Cyclobenzaprine hydrochloride361
Pantoprazole sodium354
Losartan potassium343
Venlafaxine hydrochloride348
Carbamazepine352
Olmesartan medoxomil331
Escitalopram oxalate322
Sacubitril and valsartan329
Dofetilide312
Oxcarbazepine346
Desvenlafaxine314
Telmisartan329
Repaglinide39
Vilazodone hydrochloride313
Spironolactone345
Ampicillin sodium and sulbactam sodium37
Deferasirox321
Olmesartan medoxomil and hydrochlorothiazide317
Sapropterin dihydrochloride310
Fluoxetine342
Methazolamide210
Lansoprazole258
Pemetrexed disodium214
Phenylephrine hydrochloride277
Abiraterone acetate222
Pantoprazole225
Methimazole223
Penicillin g potassium28
Famotidine2138
Tranexamic acid239
Candesartan23
Lubiprostone220
Primidone223
Fenofibrate256
Tolvaptan29
Memantine27
Daptomycin225
Valganciclovir hydrochloride211
Ibuprofen2190
Lacosamide257
Fesoterodine fumarate212
Pitavastatin calcium210
Guanfacine hydrochloride26
Ivabradine212
Doxorubicin hydrochloride220
Norepinephrine bitartrate225
Pirfenidone226
Ticagrelor232
Progesterone239
Thiamine hydrochloride218
Decitabine118
Sumatriptan succinate124
Prochlorperazine maleate131
Ofloxacin otic110
Ephedrine sulfate126
Dabigatran etexilate117
Indomethacin136
Clindamycin phosphate topical solution usp, 1%12
Eribulin mesylate117
Potassium chloride184
Nafcillin15
Gemfibrozil129
Glycopyrrolate164
Nitroglycerin140

Dosage forms

Dosage formProductsShare
Tablet10727.9%
Tablet, film coated6717.5%
Injection, solution4110.7%
Capsule389.9%
Solution164.2%
Injection153.9%
Injection, powder, for solution133.4%
Injection, powder, lyophilized, for solution82.1%
Capsule, extended release82.1%
Solution/ drops82.1%
Tablet, film coated, extended release71.8%
Tablet, delayed release71.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Norepinephrine Bitartrate72603-806Injection, solution, concentrateGeneric drugs (ANDA)October 30, 2026
Thiamine Hydrochloride72603-565Injection, solutionGeneric drugs (ANDA)October 14, 2026
Famotidine72603-564Powder, for suspensionGeneric drugs (ANDA)October 1, 2026
Colestipol hydrochloride72603-817Tablet, film coatedGeneric drugs (ANDA)September 1, 2026
Ticagrelor72603-941Tablet, film coatedGeneric drugs (ANDA)August 10, 2026
Ticagrelor72603-940Tablet, film coatedGeneric drugs (ANDA)August 10, 2026
Olmesartan medoxomil72603-952TabletGeneric drugs (ANDA)August 7, 2026
Olmesartan medoxomil72603-951TabletGeneric drugs (ANDA)August 7, 2026
Olmesartan medoxomil72603-950TabletGeneric drugs (ANDA)August 7, 2026
Tadalafil72603-784Tablet, film coatedGeneric drugs (ANDA)August 3, 2026
Tadalafil72603-783Tablet, film coatedGeneric drugs (ANDA)August 3, 2026
Tadalafil72603-782Tablet, film coatedGeneric drugs (ANDA)August 3, 2026
Tadalafil72603-781Tablet, film coatedGeneric drugs (ANDA)August 3, 2026
Progesterone72603-975CapsuleGeneric drugs (ANDA)August 1, 2026
Progesterone72603-974CapsuleGeneric drugs (ANDA)August 1, 2026
Doxepin72603-920TabletGeneric drugs (ANDA)August 1, 2026
Doxepin72603-919TabletGeneric drugs (ANDA)August 1, 2026
Clozapine72603-914TabletGeneric drugs (ANDA)August 1, 2026
Clozapine72603-913TabletGeneric drugs (ANDA)August 1, 2026
Clozapine72603-912TabletGeneric drugs (ANDA)August 1, 2026
Clozapine72603-911TabletGeneric drugs (ANDA)August 1, 2026
Tranexamic acid72603-818TabletGeneric drugs (ANDA)August 1, 2026
Sacubitril and Valsartan72603-882Tablet, film coatedGeneric drugs (ANDA)June 29, 2026
Sacubitril and Valsartan72603-881Tablet, film coatedGeneric drugs (ANDA)June 29, 2026
Sacubitril and Valsartan72603-880Tablet, film coatedGeneric drugs (ANDA)June 29, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.